Search Results - "Specker, C."

Antiphospholipid syndrome by Specker, C

“…Antiphospholipid syndrome (APS) is characterized by recurrent arterial or venous thromboembolism or pregnancy loss in association with antibodies directed…”
Get full text

Regional cooperative rheumatology centers : Networking of rheumatology in Germany for over 25 years by Gundelach, B, Specker, C

“…Over the last 25 years the regional collaborative rheumatology centers have become established throughout Germany as "catalysts" for improving rheumatological…”
Get full text

Obituary for Prof. Dr. Ernst Feldtkeller who was recipient of the DGRh Kussmaul Medal honored by the German Society for Rheumatology (DGRh) by Braun, J, Rudwaleit, M, Sieper, J, Specker, C

Get full text

Safety management in treatment with antimalarials in rheumatology. Interdisciplinary recommendations on the basis of a systematic literature review by Fiehn, C., Ness, T., Weseloh, C., Specker, C., Hadjiski, D., Detert, J., Krüger, K.

“…Background Antimalarial medication (AM) plays an important role in the treatment of rheumatic diseases. Objective Updated evidence-based recommendations on the…”
Get full text

Memorandum of the German Society for Rheumatology on the quality of treatment in rheumatology - Update 2016 by Zink, A, Braun, J, Gromnica-Ihle, E, Krause, D, Lakomek, H J, Mau, W, Müller-Ladner, U, Rautenstrauch, J, Specker, C, Schneider, M

“…On behalf of the Steering Committee of the German Society for Rheumatology, in 2016 the Interdisciplinary Commission on Healthcare Quality updated the 2008…”
Get full text

Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study by Fischer-Betz, R, Specker, C, Brinks, R, Schneider, M

“…Among the most prominent features associated with antiphospholipid syndrome (APS) are cerebral ischaemic events (CVE). Pregnancy with APS increases the risk of…”
Get full text

Statement of the German Society for Rheumatology (DGRh) on the use of video consultations in rheumatology by Aries, P, Welcker, M, Callhoff, J, Chehab, G, Krusche, M, Schneider, M, Specker, C, Richter, J G

“…For several years video consultations have been regarded as a new form of medical healthcare infrastructure, in addition to personal doctor-patient contacts…”
Get full text

S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs by Fiehn, C, Holle, J, Iking-Konert, C, Leipe, J, Weseloh, C, Frerix, M, Alten, R, Behrens, F, Baerwald, C, Braun, J, Burkhardt, H, Burmester, G, Detert, J, Gaubitz, M, Gause, A, Gromnica-Ihle, E, Kellner, H, Krause, A, Kuipers, J, Lorenz, H-M, Müller-Ladner, U, Nothacker, M, Nüsslein, H, Rubbert-Roth, A, Schneider, M, Schulze-Koops, H, Seitz, S, Sitter, H, Specker, C, Tony, H-P, Wassenberg, S, Wollenhaupt, J, Krüger, K

“…Medication-based strategies to treat rheumatoid arthritis are crucial in terms of outcome. They aim at preventing joint destruction, loss of function and…”
Get full text

Lupus and thrombophilia : Antiphospholipid syndrome by Lettau, M, Schrezenmeier, E V, Specker, C, Dörner, T

“…Even early on thromboembolic events were observed in patients with systemic lupus erythematosus (SLE) until the antiphospholipid syndrome (APS) was described…”
Get full text

The influence of the SARS-CoV-2 lockdown on patients with inflammatory rheumatic diseases on their adherence to immunomodulatory medication: a cross sectional study over 3 months in Germany by Hasseli, R, Müller-Ladner, U, Keil, F, Broll, M, Dormann, A, Fräbel, C, Hermann, W, Heinmüller, C -J, Hoyer, B F, Löffler, F, Özden, F, Pfeiffer, U, Saech, J, Schneidereit, T, Schlesinger, A, Schwarting, A, Specker, C, Stapfer, G, Steinmüller, M, Storck-Müller, K, Strunk, J, Thiele, A, Triantafyllias, K, Vagedes, D, Wassenberg, S, Wilden, E, Zeglam, S, Schmeiser, T

“…Abstract Objectives To evaluate the influence of the SARS-CoV-2 pandemic on the adherence of patients with inflammatory rheumatic diseases (IRD) to their…”
Get full text

Antiphospholipid syndrome by Specker, C

Get full text

Position paper of the commission on digital rheumatology of the German Society of Rheumatology: tasks, targets and perspectives for a modern rheumatology by Knitza, J, Callhoff, J, Chehab, G, Hueber, A, Kiltz, U, Kleyer, A, Krusche, M, Simon, D, Specker, C, Schneider, M, Voormann, A, Welcker, M, Richter, J G

Get full text

Identification of rheumatological health apps in the Apple app store applying the "semiautomatic retrospective app store analysis" method : A longitudinal observation by Richter, J G, Chehab, G, Kiltz, U, Becker, A, von Jan, U, Albrecht, U-V, Schneider, M, Specker, C

“…The Apple and Google app stores offer a wide range of health apps. It is still a challenge to find valuable and qualified apps. Can German language apps be…”
Get full text

Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) – results from a nationwide cohort in Germany (GRAID) by Witt, M, Grunke, M, Proft, F, Baeuerle, M, Aringer, M, Burmester, G, Chehab, G, Fiehn, C, Fischer-Betz, R, Fleck, M, Freivogel, K, Haubitz, M, Kötter, I, Lovric, S, Metzler, C, Rubberth-Roth, A, Schwarting, A, Specker, C, Tony, H-P, Unger, L, Wassenberg, S, Dörner, T, Schulze-Koops, H

“…ObjectiveThe objective of this article is to evaluate the safety and clinical outcome of rituximab treatment in systemic lupus erythematosus (SLE) patients…”
Get full text

SARS-CoV-2 & rheumatic disease : Consequences of the SARS-CoV-2 pandemic for patients with inflammatory rheumatic diseases. A comparison of the recommendations for action of rheumatological societies and risk assessment of different antirheumatic treatments by Leipe, J, Hoyer, B F, Iking-Konert, C, Schulze-Koops, H, Specker, C, Krüger, K

“…The recommendations of the German Society of Rheumatology (DGRh) update, which update and expand the guidance on the management of patients with inflammatory…”
Get full text

Future of acute inpatient rheumatology in Germany : Statement of the Boards of the German Society for Rheumatology and the Association of Rheumatological Acute Clinics on hospital planning North-Rhine/Westphalia 2019 for the discipline rheumatology by Lakomek, H-J, Krause, A, Braun, J, Hellmich, B, Klass, M, Lorenz, H, Schneider, M, Schulze-Koops, H, Specker, C

“…In September 2019 the Ministry of Labor, Health and Welfare (MAGS) of North-Rhine/Westphalia (NRW) published an expert report on hospital planning. In this…”
Get full text

Current state of evidence on ‘off-label’ therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland – a consensus report by Aringer, M, Burkhardt, H, Burmester, GR, Fischer-Betz, R, Fleck, M, Graninger, W, Hiepe, F, Jacobi, AM, Kötter, I, Lakomek, HJ, Lorenz, HM, Manger, B, Schett, G, Schmidt, RE, Schneider, M, Schulze-Koops, H, Smolen, JS, Specker, C, Stoll, T, Strangfeld, A, Tony, HP, Villiger, PM, Voll, R, Witte, T, Dörner, T

“…Systemic lupus erythematosus (SLE) can be a severe and potentially life-threatening disease that often represents a therapeutic challenge because of its…”
Get full text

Successful outcome of two pregnancies in patients with adult-onset Still's disease treated with IL-1 receptor antagonist (anakinra) by FISCHER-BETZ, R, SPECKER, C, SCHNEIDER, M

“…Adult onset Still's disease (AOSD) is an uncommon, systemic, inflammatory disorder of unknown etiology, characterised by spiking fevers, skin rash, and…”
Get full text

Disease-related knowledge acquisition through structured patient information in rheumatoid arthritis (StruPI-RA) : First results of the StruPI-RA study in Germany by Schwarze, M, Fieguth, V, Schuch, F, Sandner, P, Edelmann, E, Händel, A, Kettler, M, Hanke, A, Kück, M, Stein, L, Stille, C, Fellner, M, De Angelis, V, Touissant, S, Specker, C

“…The structured patient information for rheumatoid arthritis (StruPi-RA) program was the first standardized outpatient education program in rheumatoid arthritis…”
Get full text

Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic by Schulze-Koops, H, Holle, J, Moosig, F, Specker, C, Aries, P, Burmester, G, Fiehn, C, Hoyer, B, Krause, A, Leipe, J, Lorenz, H-M, Schneider, M, Sewerin, P, Voormann, A, Wager, U, Krüger, K, Iking-Konert, C

“…In the current SARS-CoV-2 pandemic there are many questions regarding the safe treatment of patients with inflammatory rheumatic diseases. Many of these…”
Get full text